The immune system's involvement in obesity-driven type 2 diabetes

被引：134
|
作者：
Shu, Chengyi Jenny [1 ]
Benoist, Christophe [1 ]
Mathis, Diane [1 ]
机构：
[1] Harvard Univ, Div Immunol, Dept Microbiol & Immunobiol, Sch Med, Boston, MA 02115 USA
来源：
SEMINARS IN IMMUNOLOGY | 2012年 / 24卷 / 06期
关键词：
Obesity; Type; 2; diabetes; Inflammation; Adipose tissue; Insulin resistance; DIET-INDUCED OBESITY; REGULATORY T-CELLS; ADIPOSE-TISSUE MACROPHAGES; INDUCED INSULIN-RESISTANCE; NECROSIS-FACTOR-ALPHA; FREE FATTY-ACIDS; B-CELLS; ALTERNATIVE ACTIVATION; NLRP3; INFLAMMASOME; UNIQUE POPULATION;
D O I：
10.1016/j.smim.2012.12.001
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Type 2 diabetes is now a worldwide epidemic, strongly correlated with an elevated incidence of obesity. Obesity-associated adipose tissue inflammation is a major cause of the decreased insulin sensitivity seen in type 2 diabetes. Recent studies have shed light on the cross-talk between the immune system and organismal metabolism. This review discusses the connection between inflammation in adipose tissue and systemic insulin resistance, focusing on the roles of innate and adaptive immune cell subsets in the pathogenesis of this metabolic disease. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码：436 / 442
页数：7
相关论文
共 50 条
  • [21] Myokines: metabolic regulation in obesity and type 2 diabetes
    Chen, Zhi-Tian
    Weng, Zhi-Xuan
    Lin, Jiandie D.
    Meng, Zhuo-Xian
    LIFE METABOLISM, 2024, 3 (03):
  • [22] Galectin-1 in Obesity and Type 2 Diabetes
    Fryk, Emanuel
    Silva, Vagner R. R.
    Jansson, Per-Anders
    METABOLITES, 2022, 12 (10)
  • [23] T Cell Populations and Functions Are Altered in Human Obesity and Type 2 Diabetes
    Touch, Sothea
    Clement, Karine
    Andre, Sebastien
    CURRENT DIABETES REPORTS, 2017, 17 (09)
  • [24] Chaperoning to the metabolic party: The emerging therapeutic role of heat-shock proteins in obesity and type 2 diabetes
    Henstridge, Darren C.
    Whitham, Martin
    Febbraio, Mark A.
    MOLECULAR METABOLISM, 2014, 3 (08): : 781 - 793
  • [25] Targeting obesity, insulin resistance and Type 2 diabetes with immunotherapy: the challenges ahead
    Fujii, Masakazu
    Sonoda, Noriyuki
    Takayanagi, Ryoichi
    Inoguchi, Tosyoshi
    IMMUNOTHERAPY, 2014, 6 (01) : 5 - 7
  • [26] The involvement of microRNAs in Type 2 diabetes
    McCullough, David Ferland
    Ozanne, Susan E.
    Siddle, Kenneth
    Willis, Anne E.
    Bushell, Martin
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2010, 38 : 1565 - 1570
  • [27] Adipose tissue immune cells in obesity, type 2 diabetes mellitus and cardiovascular diseases
    Cinkajzlova, Anna
    Mraz, Milos
    Haluzik, Martin
    JOURNAL OF ENDOCRINOLOGY, 2022, 252 (01) : R1 - R22
  • [28] MicroRNAs and Type 2 Diabetes/Obesity
    Dehwah, Mustafa Abdo Saif
    Xu, Aimin
    Huang, Qingyang
    JOURNAL OF GENETICS AND GENOMICS, 2012, 39 (01) : 11 - 18
  • [29] Fetuin-A and angiopoietins in obesity and type 2 diabetes mellitus
    Rasul, Sazan
    Wagner, Ludwig
    Kautzky-Willer, Alexandra
    ENDOCRINE, 2012, 42 (03) : 496 - 505
  • [30] Adipokines: Role in the pathophysiology and therapy of obesity and type 2 diabetes
    Fasshauer, Mathias
    Blueher, Matthias
    LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE, 2009, 33 (01): : 1 - 6
12345